Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Biologic therapy. Chemotherapy. Shan Dong Tumor Hospital, Shandong, China

Survival: 11.2 months
Toxicity Grade: 3
Treatments: Biologic therapy
Drugs: Pemetrexed
Country: China
City/State/Province: Shandong
Hospital: Shan Dong Tumor Hospital
Journal: Link
Date: 1/2015

This study involved 27 previously treated primary central nervous system lymphoma patients. The median patient age was 53.5 years and 62.9% were male.

Patients received chemotherapy with pemetrexed and biologic therapy with rituximab.

The most severe toxicities were of grade 3 and included leukocytopenia, thrombocytopenia, and neutropenia. Grade 1-2 nausea/vomiting and stomatitis (inflammation of mouth and lips) were also reported.

The median overall survival was 11.2 months.

Correspondence: Dr. Rong-Jie Tao; email:

E-mail to a Friend Email Physician More Information